Author:
Watanabe Yukihiro,Sato Hiroshi,Takase Kenichiro,Takeshita Hiroki,Sakuramoto Shinichi,Niihara Masahiro,Tsubosa Yasuhiro,Koyama Isamu
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Ohtsu A, Boku N, Muro K, et al. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999;17:2915–21.
2. Osaka Y, Takagi Y, Tsuchida A, et al. Concurrent preoperative chemoradiotherapy for stage III or IV esophageal squamous carcinoma. Oncol Rep. 2004;12:1121–6.
3. Kinsman KJ, DeGregorio BT, Katon RM, et al. Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancy. Gastrointest Endosc. 1996;43:196–203.
4. Bethge N, Sommer A, von Kleist D, et al. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal obstruction after failure of primary curative therapy. Gastrointest Endosc. 1996;44:283–6.
5. Iizuka T, Kakegawa T, Ide H, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol. 1992;22:172–6.